Compounds > 4-butyrolactone
Page last updated: 2024-08-18

4-butyrolactone and Liver Neoplasms

4-butyrolactone has been researched along with Liver Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's5 (55.56)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Cavalluzzi, MM; Denora, N; Gnocchi, D; Kapoor, S; Lentini, G; Mazzocca, A; Nitti, P; Sabbà, C1
Chiang, BH; Li, TY1
Cheng, X; Li, L; Uttamchandani, M; Yao, SQ1
Alhammady, MA; El-Beih, AA; Elkhateeb, A; Gamal-Eldeen, AM; Hegazy, ME; Ohta, S; Paré, PW1
Chang, CH; Chang, WL; Chung, CH; Hsu, CC; Huang, TF; Ko, FN; Lin, KT; Peng, HC; Wang, SW1
Chiang, BH; Kuo, YH; Lin, YW; Liu, RH; Pan, JH; Sheen, LY1
Huber, WW; Knasmuller, S; Prustomersky, S; Scharf, G; Schulte-Hermann, R1
Chen, Y; Ding, J; Gao, Y; Hou, YT; Lin, LP; Zhu, CH1
Gores, GJ; Malhi, H1

Other Studies

9 other study(ies) available for 4-butyrolactone and Liver Neoplasms

ArticleYear
Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function.
    Journal of molecular medicine (Berlin, Germany), 2020, Volume: 98, Issue:2

    Topics: 4-Butyrolactone; Acetates; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Mice, Nude; Mitochondria; Receptors, Lysophosphatidic Acid

2020
4-Acetylantroquinonol B from antrodia cinnamomea enhances immune function of dendritic cells against liver cancer stem cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 109

    Topics: 4-Butyrolactone; Animals; Antrodia; Cell Survival; Coculture Techniques; Cyclohexanones; Dendritic Cells; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Immunity, Cellular; Liver Neoplasms; Mice; Neoplastic Stem Cells; RAW 264.7 Cells

2019
In situ proteome profiling of C75, a covalent bioactive compound with potential anticancer activities.
    Organic letters, 2014, Mar-07, Volume: 16, Issue:5

    Topics: 4-Butyrolactone; Antineoplastic Agents; Apoptosis; Humans; Liver Neoplasms; Molecular Structure; Small Molecule Libraries

2014
New terpenes from the Egyptian soft coral Sarcophyton ehrenbergi.
    Marine drugs, 2014, Apr-02, Volume: 12, Issue:4

    Topics: 4-Butyrolactone; Adenocarcinoma; Animals; Anthozoa; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Hepatocellular; Egypt; Hep G2 Cells; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; MCF-7 Cells; Terpenes

2014
4-Acetylantroquinonol B suppresses tumor growth and metastasis of hepatoma cells via blockade of translation-dependent signaling pathway and VEGF production.
    Journal of agricultural and food chemistry, 2015, Jan-14, Volume: 63, Issue:1

    Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Antrodia; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Cyclohexanones; Down-Regulation; Hep G2 Cells; Humans; Liver Neoplasms; Male; Metatarsal Bones; Mice, Nude; Mice, SCID; Phosphorylation; Protein Biosynthesis; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A

2015
The 4-acetylantroquinonol B isolated from mycelium of Antrodia cinnamomea inhibits proliferation of hepatoma cells.
    Journal of the science of food and agriculture, 2010, Aug-15, Volume: 90, Issue:10

    Topics: 4-Butyrolactone; Antineoplastic Agents; Antrodia; Biological Products; Carcinoma, Hepatocellular; Cell Proliferation; Cyclohexanones; Fermentation; Hep G2 Cells; Humans; Liver Neoplasms; Mycelium

2010
Enhancement of glutathione and g-glutamylcysteine synthetase, the rate limiting enzyme of glutathione synthesis, by chemoprotective plant-derived food and beverage components in the human hepatoma cell line HepG2.
    Nutrition and cancer, 2003, Volume: 45, Issue:1

    Topics: 4-Butyrolactone; Allyl Compounds; Animals; Anticarcinogenic Agents; Cell Line, Tumor; Diterpenes; Dose-Response Relationship, Drug; Glutamate-Cysteine Ligase; Glutathione; Glutathione Synthase; Hepatoblastoma; Humans; Isothiocyanates; Liver; Liver Neoplasms; Quercetin; Sulfides

2003
Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma.
    Cancer biology & therapy, 2006, Volume: 5, Issue:8

    Topics: 4-Butyrolactone; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Cyclin A; Cyclin B; Cyclin B1; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; fas Receptor; Fatty Acid Synthases; Flow Cytometry; G2 Phase; Humans; Immunoprecipitation; Liver Neoplasms; p38 Mitogen-Activated Protein Kinases; Plasmids; RNA, Small Interfering; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2006
Cancer therapy: back to metabolism.
    Cancer biology & therapy, 2006, Volume: 5, Issue:8

    Topics: 4-Butyrolactone; Carcinoma, Hepatocellular; Cell Cycle; fas Receptor; Fatty Acid Synthases; Fatty Acids; Humans; Liver Neoplasms; p38 Mitogen-Activated Protein Kinases; Tumor Suppressor Protein p53

2006